ID   CTDS2_HUMAN             Reviewed;         271 AA.
AC   O14595; A8K5H4; Q53ZR2; Q6NZY3; Q9UEX1;
DT   13-DEC-2001, integrated into UniProtKB/Swiss-Prot.
DT   09-NOV-2004, sequence version 2.
DT   12-APR-2017, entry version 141.
DE   RecName: Full=Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 2;
DE            EC=3.1.3.16;
DE   AltName: Full=Nuclear LIM interactor-interacting factor 2;
DE            Short=NLI-interacting factor 2;
DE   AltName: Full=Protein OS-4;
DE   AltName: Full=Small C-terminal domain phosphatase 2;
DE   AltName: Full=Small CTD phosphatase 2;
DE            Short=SCP2;
GN   Name=CTDSP2; Synonyms=NIF2, OS4, SCP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9315096; DOI=10.1038/sj.onc.1201294;
RA   Su Y.A., Lee M.M., Hutter C.M., Meltzer P.S.;
RT   "Characterization of a highly conserved gene (OS4) amplified with CDK4
RT   in human sarcomas.";
RL   Oncogene 15:1289-1294(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RX   PubMed=12721286; DOI=10.1074/jbc.M301791200;
RA   Yeo M., Lin P.S., Dahmus M.E., Gill G.N.;
RT   "A novel RNA polymerase II C-terminal domain phosphatase that
RT   preferentially dephosphorylates serine 5.";
RL   J. Biol. Chem. 278:26078-26085(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Fetal pancreas;
RA   Morikane K., Hollingsworth M.A.;
RL   Submitted (SEP-1997) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Leukocyte;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   FUNCTION, TISSUE SPECIFICITY, AND INTERACTION WITH REST.
RX   PubMed=15681389; DOI=10.1126/science.1100801;
RA   Yeo M., Lee S.-K., Lee B., Ruiz E.C., Pfaff S.L., Gill G.N.;
RT   "Small CTD phosphatases function in silencing neuronal gene
RT   expression.";
RL   Science 307:596-600(2005).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-5, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.51 ANGSTROMS) OF 87-271 IN COMPLEX WITH
RP   MAGNESIUM.
RX   PubMed=18058037; DOI=10.1007/s10969-007-9036-1;
RA   Almo S.C., Bonanno J.B., Sauder J.M., Emtage S., Dilorenzo T.P.,
RA   Malashkevich V., Wasserman S.R., Swaminathan S., Eswaramoorthy S.,
RA   Agarwal R., Kumaran D., Madegowda M., Ragumani S., Patskovsky Y.,
RA   Alvarado J., Ramagopal U.A., Faber-Barata J., Chance M.R., Sali A.,
RA   Fiser A., Zhang Z.Y., Lawrence D.S., Burley S.K.;
RT   "Structural genomics of protein phosphatases.";
RL   J. Struct. Funct. Genomics 8:121-140(2007).
CC   -!- FUNCTION: Preferentially catalyzes the dephosphorylation of 'Ser-
CC       5' within the tandem 7 residue repeats in the C-terminal domain
CC       (CTD) of the largest RNA polymerase II subunit POLR2A. Negatively
CC       regulates RNA polymerase II transcription, possibly by controlling
CC       the transition from initiation/capping to processive transcript
CC       elongation. Recruited by REST to neuronal genes that contain RE-1
CC       elements, leading to neuronal gene silencing in non-neuronal
CC       cells. May contribute to the development of sarcomas.
CC       {ECO:0000269|PubMed:12721286, ECO:0000269|PubMed:15681389}.
CC   -!- CATALYTIC ACTIVITY: [a protein]-serine/threonine phosphate + H(2)O
CC       = [a protein]-serine/threonine + phosphate.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC       Note=Binds 1 Mg(2+) ion per monomer.;
CC   -!- SUBUNIT: Monomer (By similarity). Interacts with REST.
CC       {ECO:0000250, ECO:0000269|PubMed:15681389,
CC       ECO:0000269|PubMed:18058037}.
CC   -!- INTERACTION:
CC       P10275:AR; NbExp=3; IntAct=EBI-2802973, EBI-608057;
CC       Q99618:CDCA3; NbExp=5; IntAct=EBI-2802973, EBI-739534;
CC       P14079:tax (xeno); NbExp=3; IntAct=EBI-2802973, EBI-9675698;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expression is restricted to non-neuronal
CC       tissues. Highest expression in pancreas and lowest in liver.
CC       {ECO:0000269|PubMed:15681389}.
CC   -!- INDUCTION: In primary sarcomas.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB71816.1; Type=Frameshift; Positions=267; Evidence={ECO:0000305};
CC       Sequence=AAP34399.1; Type=Frameshift; Positions=267; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF000152; AAB71816.1; ALT_FRAME; mRNA.
DR   EMBL; AY279531; AAP34399.1; ALT_FRAME; mRNA.
DR   EMBL; AF022231; AAD09331.1; -; mRNA.
DR   EMBL; AK291289; BAF83978.1; -; mRNA.
DR   EMBL; CH471054; EAW97083.1; -; Genomic_DNA.
DR   EMBL; BC065920; AAH65920.1; -; mRNA.
DR   CCDS; CCDS41801.1; -.
DR   RefSeq; NP_005721.3; NM_005730.3.
DR   UniGene; Hs.524530; -.
DR   PDB; 2Q5E; X-ray; 2.51 A; A/B/C/D/E/F/G/H=87-271.
DR   PDBsum; 2Q5E; -.
DR   ProteinModelPortal; O14595; -.
DR   SMR; O14595; -.
DR   BioGrid; 115412; 24.
DR   DIP; DIP-61245N; -.
DR   IntAct; O14595; 10.
DR   MINT; MINT-2735588; -.
DR   STRING; 9606.ENSP00000381148; -.
DR   DEPOD; O14595; -.
DR   iPTMnet; O14595; -.
DR   PhosphoSitePlus; O14595; -.
DR   SwissPalm; O14595; -.
DR   BioMuta; CTDSP2; -.
DR   EPD; O14595; -.
DR   MaxQB; O14595; -.
DR   PaxDb; O14595; -.
DR   PeptideAtlas; O14595; -.
DR   PRIDE; O14595; -.
DR   DNASU; 10106; -.
DR   Ensembl; ENST00000398073; ENSP00000381148; ENSG00000175215.
DR   GeneID; 10106; -.
DR   KEGG; hsa:10106; -.
DR   UCSC; uc001sqm.4; human.
DR   CTD; 10106; -.
DR   DisGeNET; 10106; -.
DR   GeneCards; CTDSP2; -.
DR   HGNC; HGNC:17077; CTDSP2.
DR   HPA; HPA052607; -.
DR   MIM; 608711; gene.
DR   neXtProt; NX_O14595; -.
DR   OpenTargets; ENSG00000175215; -.
DR   PharmGKB; PA128394568; -.
DR   eggNOG; KOG1605; Eukaryota.
DR   eggNOG; COG5190; LUCA.
DR   GeneTree; ENSGT00390000017194; -.
DR   HOGENOM; HOG000236379; -.
DR   HOVERGEN; HBG053298; -.
DR   InParanoid; O14595; -.
DR   KO; K15731; -.
DR   PhylomeDB; O14595; -.
DR   TreeFam; TF313556; -.
DR   Reactome; R-HSA-381038; XBP1(S) activates chaperone genes.
DR   SignaLink; O14595; -.
DR   SIGNOR; O14595; -.
DR   ChiTaRS; CTDSP2; human.
DR   EvolutionaryTrace; O14595; -.
DR   GeneWiki; CTDSP2; -.
DR   GenomeRNAi; 10106; -.
DR   PRO; PR:O14595; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000175215; -.
DR   CleanEx; HS_CTDSP2; -.
DR   CleanEx; HS_SCP2; -.
DR   ExpressionAtlas; O14595; baseline and differential.
DR   Genevisible; O14595; HS.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0008420; F:CTD phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0036498; P:IRE1-mediated unfolded protein response; TAS:Reactome.
DR   GO; GO:2000134; P:negative regulation of G1/S transition of mitotic cell cycle; IEA:Ensembl.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; IEA:Ensembl.
DR   GO; GO:0006470; P:protein dephosphorylation; IDA:UniProtKB.
DR   Gene3D; 3.40.50.1000; -; 1.
DR   InterPro; IPR011948; Dullard_phosphatase.
DR   InterPro; IPR004274; FCP1_dom.
DR   InterPro; IPR023214; HAD-like_dom.
DR   Pfam; PF03031; NIF; 1.
DR   SMART; SM00577; CPDc; 1.
DR   SUPFAM; SSF56784; SSF56784; 1.
DR   TIGRFAMs; TIGR02251; HIF-SF_euk; 1.
DR   PROSITE; PS50969; FCP1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Hydrolase; Metal-binding; Nucleus;
KW   Phosphoprotein; Protein phosphatase; Reference proteome.
FT   CHAIN         1    271       Carboxy-terminal domain RNA polymerase II
FT                                polypeptide A small phosphatase 2.
FT                                /FTId=PRO_0000212574.
FT   DOMAIN       97    255       FCP1 homology. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00336}.
FT   ACT_SITE    107    107       4-aspartylphosphate intermediate.
FT                                {ECO:0000250}.
FT   ACT_SITE    109    109       Proton donor. {ECO:0000250}.
FT   METAL       107    107       Magnesium. {ECO:0000269|PubMed:18058037}.
FT   METAL       109    109       Magnesium; via carbonyl oxygen.
FT                                {ECO:0000269|PubMed:18058037}.
FT   METAL       218    218       Magnesium. {ECO:0000269|PubMed:18058037}.
FT   SITE        163    163       Transition state stabilizer.
FT                                {ECO:0000250}.
FT   SITE        201    201       Transition state stabilizer.
FT                                {ECO:0000250}.
FT   MOD_RES       5      5       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CONFLICT      9      9       Q -> H (in Ref. 3; AAD09331).
FT                                {ECO:0000305}.
FT   TURN         96    100       {ECO:0000244|PDB:2Q5E}.
FT   STRAND      103    106       {ECO:0000244|PDB:2Q5E}.
FT   TURN        110    112       {ECO:0000244|PDB:2Q5E}.
FT   STRAND      113    118       {ECO:0000244|PDB:2Q5E}.
FT   STRAND      124    131       {ECO:0000244|PDB:2Q5E}.
FT   STRAND      134    142       {ECO:0000244|PDB:2Q5E}.
FT   HELIX       146    156       {ECO:0000244|PDB:2Q5E}.
FT   STRAND      157    162       {ECO:0000244|PDB:2Q5E}.
FT   HELIX       167    177       {ECO:0000244|PDB:2Q5E}.
FT   STRAND      183    187       {ECO:0000244|PDB:2Q5E}.
FT   HELIX       189    191       {ECO:0000244|PDB:2Q5E}.
FT   STRAND      192    195       {ECO:0000244|PDB:2Q5E}.
FT   STRAND      198    200       {ECO:0000244|PDB:2Q5E}.
FT   HELIX       203    205       {ECO:0000244|PDB:2Q5E}.
FT   STRAND      206    208       {ECO:0000244|PDB:2Q5E}.
FT   HELIX       210    212       {ECO:0000244|PDB:2Q5E}.
FT   STRAND      213    218       {ECO:0000244|PDB:2Q5E}.
FT   HELIX       220    223       {ECO:0000244|PDB:2Q5E}.
FT   HELIX       227    229       {ECO:0000244|PDB:2Q5E}.
FT   STRAND      230    232       {ECO:0000244|PDB:2Q5E}.
FT   HELIX       244    255       {ECO:0000244|PDB:2Q5E}.
FT   HELIX       261    268       {ECO:0000244|PDB:2Q5E}.
SQ   SEQUENCE   271 AA;  30664 MW;  E4FA4A1657F2B03F CRC64;
     MEHGSIITQA RREDALVLTK QGLVSKSSPK KPRGRNIFKA LFCCFRAQHV GQSSSSTELA
     AYKEEANTIA KSDLLQCLQY QFYQIPGTCL LPEVTEEDQG RICVVIDLDE TLVHSSFKPI
     NNADFIVPIE IEGTTHQVYV LKRPYVDEFL RRMGELFECV LFTASLAKYA DPVTDLLDRC
     GVFRARLFRE SCVFHQGCYV KDLSRLGRDL RKTLILDNSP ASYIFHPENA VPVQSWFDDM
     ADTELLNLIP IFEELSGAED VYTSLGQLRA P
//
